Richard Ferrari - 01 Jun 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Richard M. Ferrari
Issuer symbol
LUNG
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 20:12:43 UTC
Next filing
12 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Award $0 +2,810 +17% $0.000000 18,997 01 Jun 2021 Direct F1
holding LUNG Common Stock 1,232,321 01 Jun 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021.
F2 The shares are directly held by De Novo Ventures III Liquidating Trust ("De Novo"). The Reporting Person, along with Fred Dozier and Joseph Mandato, and Jay Watkins are the trustees of De Novo and exercise voting and dispositive control over the shares held by De Novo.